EAM Investors, LLC - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is and the CUSIP is 834203309. A total of 80 filers reported holding SOLENO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.8%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$2,756,791
-26.7%
64,411
-31.1%
0.43%
-35.5%
Q4 2023$3,760,356
-8.5%
93,425
-32.9%
0.67%
-15.9%
Q3 2023$4,111,628139,3300.79%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 7,316,851$298,527,52127.58%
Carlyle Group Inc. 4,071,562$166,364,02315.80%
Nantahala Capital Management 3,082,107$125,749,9667.40%
Ally Bridge Group (NY) LLC 286,162$11,675,4106.96%
COMMODORE CAPITAL LP 1,425,000$58,140,0003.97%
Ghost Tree Capital, LLC 300,000$12,240,0003.83%
Vestal Point Capital, LP 1,200,000$48,960,0003.65%
Altium Capital Management LP 212,909$8,686,6873.54%
Ikarian Capital, LLC 445,451$18,174,4013.17%
Perceptive Advisors 3,204,976$130,763,0213.15%
View complete list of SOLENO THERAPEUTICS INC shareholders